Blog
Can Rising Electrolyzer Demand be a Catalyst for PLUG's Long-Term Growth?
Plug Power Inc.’s PLUG electrolyzer product line is emerging as the primary growth driver. In the second quarter of 2025, revenues from this product line surged approximately 200% on a
Can Howmet Sustain Growth as Commercial Aerospace Demand Surges?
The strongest driver of Howmet Aerospace Inc.’s HWM business at the moment is the commercial aerospace market. Revenues from the market increased 8% year over year in the second quarter of 2025
3 Industrial Services Stocks to Buy as Industry Prospects Improve
D or EXC: Which Is a Better-Positioned Electric Power Stock?
Utility service providers continue to reap benefits from several positive variables, including increased electricity tariffs, accretive acquisitions, cost reductions, and the deployment of
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics, Inc. ANGO reported a pro-forma adjusted loss per share of 10 cents for first-quarter fiscal 2026, marking an improvement from the year-ago quarter’s adjusted loss of 11 cents. The
Credo Acquires Hyperlume, Taps MicroLED Tech for AI Data Centers
Credo Technology Group Holding Ltd. CRDO recently acquired Hyperlume, Inc., a privately held developer of miniature light-emitting diode (microLED) technology-based optical interconnects for
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Hologic, Inc. HOLX recently received FDA 510(k) clearance for its Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. Additionally, the assays obtained CE marking in the
Beyond Tesla: Why GM and Ford Heavy ETFs Could Be Safer Bets Now?
Electric vehicle (EV) giant Tesla (TSLA) made a stunning comeback recently, with its third-quarter 2025 delivery numbers surging 7% year over year, comfortably surpassing the weak performance of the
Space Exploration ETF (ARKX) Hits New 52-Week High
For investors seeking momentum, ARK Space Exploration & Innovation ETF (ARKX) is probably on the radar. The fund just hit a 52-week high and soared 97.4% from its 52-week low of $15.07 per share.
Choice Hotels to Strengthen French Portfolio With 50 New Properties
Choice Hotels International, Inc. CHH plans to strengthen its position in Europe’s largest hotel franchise market by adding 50 new properties in France, totaling more than 4,800 rooms. This will
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
The
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The best way to shortlist great
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
Transocean Expands $243M Backlog With BP and Petrobras Deals
Transocean Ltd. RIG, a leader in offshore drilling, has secured major new contracts for two of its ultra-deepwater drillships. These deals represent a key step forward in the company’s growth and
M&A Deals Thriving in 2025: ETFs in Focus
Wall Street is experiencing a blockbuster year for mergers and acquisitions. So far, companies have announced 49 global transactions worth more than $10 billion each, according to Mergermarket, as
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
An updated edition of the August 12, 2025 article.
The health and fitness industry has evolved from a niche pursuit to a global growth engine, fueled by a stronger cultural focus on healthier
Is Vanguard Total Bond Market Index Admiral (VBTLX) a Strong Mutual Fund Pick Right Now?
Looking for a Index fund? You may want to consider Vanguard Total Bond Market Index Admiral (VBTLX) as a possible option. While this fund is not tracked by the Zacks Mutual Fund Rank, we were able
Is Fidelity Mid Cap Value Fund (FSMVX) a Strong Mutual Fund Pick Right Now?
Looking for a Mid Cap Value fund? You may want to consider Fidelity Mid Cap Value Fund (FSMVX) as a possible option. FSMVX bears a Zacks Mutual Fund Rank of 3 (Hold), which is based on various
Is Janus Henderson Global Technology A (JATAX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for Sector - Tech funds, consider Janus Henderson Global Technology A (JATAX) as a possibility. JATAX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on
Is American Funds Capital Income Builder A (CAIBX) a Strong Mutual Fund Pick Right Now?
On the lookout for a Large Cap Blend fund? Starting with American Funds Capital Income Builder A (CAIBX) is one possibility. CAIBX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is
Is American Funds EuroPacific Growth A (AEPGX) a Strong Mutual Fund Pick Right Now?
There are plenty of choices in the Non US - Equity category, but where should you start your research? Well, one fund that may not be worth investigating is American Funds EuroPacific Growth A
Time for Emerging Markets ETFs?
Emerging-market stocks recorded the ninth consecutive month of gains — the longest winning streak since 2004 — thanks to accelerating inflows and strong demand for Asian technology shares, per a
Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - Large Cap Value category of the market, the SPDR S&P Dividend ETF (SDY) is a smart beta exchange traded fund launched on 11/08/2005.
What Are
Should Vanguard Russell 2000 Value ETF (VTWV) Be on Your Investing Radar?
Designed to provide broad exposure to the Small Cap Value segment of the US equity market, the Vanguard Russell 2000 Value ETF (VTWV) is a passively managed exchange traded fund launched on
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
What Are Smart Beta


